European Pharmacopoeia to get chapter on microbiological control of tissue

Published: 2-Aug-2016
Microbiology Pharmaceutical

EDQM is running a survey to gather information from stakeholders on monitoring microbiological control


The European Pharmacopoeia (Ph. Eur.) Commission has decided to produce a new general chapter on microbiological control of tissue.

It is currently running a survey to gather information from relevant stakeholders to enable the Ph. Eur. experts in charge of the elaboration of this chapter to have a clear vision on the current situation regarding the characteristics of tissue preparations used in Europe and how they are monitored with regard to microbiological control.

This survey will end on 2nd September 2016.

The EDQM will publish its 9th Edition of the Ph. Eur. this year. It will contain nearly 3000 monographs and general texts and will become legally binding across the continent on 1st January 2017.

The EDQM is organising an international conference to mark the publication of the 9th Edition of the European Pharmacopoeia (Ph. Eur.).

The conference – Ph. Eur.: Tackling future challenges of the Quality of Medicines together – will take place in Tallinn, Estonia on 27–28 September 2016.

See more

You may also like

Distribution

Tower Cold Chain’ industry-first shipping container design

Read more
The pyramidal solution allows pharmaceuticals to be shipped at a consistent temperature between -60°C to above +20°C for up to 96 hours

Trending Articles

  1. Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222 Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the vaccine candidate drug substance commencing late in the third quarter of 2020
  2. Sanofi Pasteur launches 5-in-1 combination vaccine in China New vaccine Pentaxim reduces number of infant injections from 12 to four
  3. The significance of the perfect gelatin in softgel production Capsule dosage forms, including soft gelatin capsules, continue to experience growing popularity throughout the pharmaceutical and nutraceutical market because of their advantages compared with other delivery forms
  4. Indian government bans three medicines owing to health risks Decision follows strong stand on suspending marketing of all drugs prohibited for sale in other countries, including the US, UK, EU and Australia
  5. Building strong foundations for a resilient and planet-friendly future Having recently released its inaugural environmental, social and governance (ESG) report, Dr Kevin Robinson caught up with Gigi Bat-Erdene, Global ESG Program Manager at PCI Pharma Services, to find out how this leading CDMO is tackling climate science, workforce empowerment, responsible waste management and supply chain security

Upcoming event

Cleanroom Conference UK

22–23 May 2024 | Exhibition | Birmingham, UK See all

You may also like

Distribution

Tower Cold Chain’ industry-first shipping container design

The pyramidal solution allows pharmaceuticals to be shipped at a consistent temperature between -60°C to above +20°C for up to 96 hours
Pharmaceutical

High-precision temperature control solutions for the pharmaceutical industry and biotechnology, available in the UK from Labtex

Huber offers a world-renowned range of temperature control systems and associated accessories for the Pharmaceutical Industry and Biotechnology
Sustainability

Building strong foundations for a resilient and planet-friendly future

Having recently released its inaugural environmental, social and governance (ESG) report, Dr Kevin Robinson caught up with Gigi Bat-Erdene, Global ESG Program Manager at PCI Pharma Services, to find out how this leading CDMO is tackling climate science, workforce empowerment, responsible waste management and supply chain security
Sustainability

Dickson achieves ISO 14001 certification

ISO 14001 certification highlights a companies' long-term efforts to manage its environmental impact
Regulatory

The key role of IVDs in healthcare: challenges to commercialisation and access

In simple terms, in vitro diagnostic (IVD) tests are done on samples such as blood or tissue that have been taken from the human body. IVDs can detect diseases, conditions and infections, provide patients with a better understanding of their ailment and how it might be managed and changed with treatment
Distribution

Tower Cold Chain launches live tracking and monitoring for pharmaceutical distribution

The upgrade allows customers to access real-time insights into shipments, facilitating the optimisation of cold chain processes
Manufacturing

Europe’s generic medicines are disappearing, study finds

Over a ten year period, the number of generic medicines withdrawn from the market increased by 12%
Subscribe now